# EDGAR Filing Document

**Accession Number:** 0001873093
**File Stem:** 0000000000-25-006436
**Filing Date:** 2025-6
**Character Count:** 2287
**Document Hash:** a85c311de41f231c22ab9e216c5ad92b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006436.hdr.sgml**: 20250722

**ACCESSION NUMBER**: 0000000000-25-006436

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250618

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CytoMed Therapeutics Ltd
- **CENTRAL INDEX KEY:** 0001873093
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** U0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-288033

**BUSINESS ADDRESS:**
- **STREET 1:** #08-22 ONE COMMONWEALTH
- **CITY:** 1 COMMONWEALTH LANE
- **STATE:** U0
- **ZIP:** 149544
- **BUSINESS PHONE:** 603824911

**MAIL ADDRESS:**
- **STREET 1:** #08-22 ONE COMMONWEALTH
- **CITY:** 1 COMMONWEALTH LANE
- **STATE:** U0
- **ZIP:** 149544

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CytoMed Therapeutics Pte. Ltd.
- **DATE OF NAME CHANGE:** 20210716
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001641172-25-015075

## Text-Extract

```

                                                           June 18, 2025

Choo Chee Kong
Chairman & Director
CytoMed Therapeutics Limited
1 Commonwealth Lane
#08-22
Singapore 149544

       Re: CytoMed Therapeutics Limited
           Registration Statement on Form F-3
           Filed June 13, 2025
           File No. 333-288033
Dear Choo Chee Kong:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Tim Buchmiller at 202-551-3635 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:   Yarona L. Yieh, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._